CD-12 Expectations: A survey of iHangout CYDY Board

New Post Public Reply Private Reply Replies (5) Message Board
Borel Fields
956
CD-12 Expectations: A survey of iHangout CYDY Board Members

“The TOP LINE REPORT on what we expect from the TOP LINE REPORT”

Thirty-nine iHangout CYDY Board members provided their best estimates of deaths in each arm of the trial. Data were collected 2/11 through 2/14.

==> Only two of 39 projections non-significant at P=.05, only one more non-significant at P=.01.

==> The Median Case: 43 treatment deaths + 45 control deaths = 88 total; P=.0004, Relative risk 0.52 (95% CI 0.36 - 0.75), Absolute lives saved 15.6 per hundred treated.



Results for Individual Variables

Total deaths

Median total deaths were forecast at 89, with a tight intra-quartile range of 87 to 90. Only 2 respondents were above 92, and only 2 below 82. The distribution was skewed but smooth, with the long low-end tail reflecting those who believe substantial deaths occurred post day-28.

Deaths in the Control Arm

Median control arm deaths were forecast at 43, or 32.8%, with in intra-quartile range of 40 (30.5%) to 47 (35.9%). The lowest six estimates were 34, 36, 38 and three at 39. Thirty-nine is important because it allows 91 total deaths for significance, while 38 only allows 88. There was a long high-end tail to this distribution with six estimates of 54 or over.

Deaths in the Treatment Arm

Median treatment arm deaths were forecast at 45, or 17.2%, with in intra-quartile range of 38 (14.5%) to 47 (17.9%). Only four estimates were above 49, while the long low-end tail showed four projections below 31.

Relative Risk and Significance

Only two cases were not significant at p=.05, only one more non-significant at p=.01.

Median relative risk was forecast at 0.52, or a 48% reduction in likelihood of an individual dying versus the control group. The intra-quartile range is 0.59 down to 0.39. There was a long tail on this distribution with six respondents indicating a risk reduction of 2/3 or more.


Absolute Risk Reduction

Median case showed absolute lives saved at 15.6 per hundred treated: 32.8 in the control group down to 17.2 the treatment arm The interquartile range was 12.6 to 21.4. Five cases in the long tail showed lives saved per hundred treated at over 30.

(Note: I use "deaths per hundred treated" as quoting this in percentage points loses the fact these are lives!)



CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Experience Urban Living: Discover Rosie in Downtown

Updated Category News Views 209

Welcome to Rosie: A New Urban Experience Rosie has officially opened its doors in downtown, welcoming residents to a new way of city living. With modern furnished apartments and stunning rooftop views, Rosie is designed to be the ultimate urban hot spot for those seeking convenience and quality. Stylish and Efficient Living Spaces This impressive 19-story building offers...

Continue Reading
Bitdefender's Triumph in Cybersecurity Performance Tests

Updated Category News Views 123

Bitdefender's Success in Cybersecurity Testing Bitdefender, a renowned name in the cybersecurity industry, has marked its territory by achieving exceptional results in the recent AV-Comparatives Business Security Test. The company was awarded the prestigious Approved Business Product Award, coming out on top among 17 cybersecurity vendors. Bitdefender's performance was...

Continue Reading
Philz Coffee Revolutionizes Ordering with App Clips Feature

Updated Category News Views 372

Philz Coffee Enhances Ordering Experience with App Clips Philz Coffee, a beloved brand known for its unique blends and commitment to quality, is taking a significant step forward by integrating App Clips into its ordering system. This move aims to streamline the process for customers who want their favorite drinks and food quickly and conveniently, without the need for a...

Continue Reading
SciSparc Ends AutoMax Merger Plans Amid New Focus

Updated Category News Views 162

SciSparc Cancels Merger with AutoMax Motors SciSparc Ltd. (NASDAQ: SPRC) has announced the mutual termination of its planned merger with AutoMax Motors Ltd, effectively putting an end to a deal that intended to expand SciSparc's operations into the automotive sector. This decision reflects the company's strategic shift as they recalibrate priorities following financial...

Continue Reading
Grogo App Clinches NAPPA Award as Summer Heats Up

Updated Category News Views 7

Grogo Reigns Supreme: Securing Another NAPPA Title It looks like Grogo's at it again, scooping up a second consecutive National Parenting Products Award (NAPPA). Yeah, this ain't just beginner's luck. Named the top app for kids, Grogo rides the summer wave right when parents are bracing for battles with screens. Makes you wonder if it's purely about the learning or if...

Continue Reading